Elanco Animal Health (ELAN) Competitors $14.40 -0.18 (-1.26%) Closing price 07/29/2025 03:59 PM EasternExtended Trading$14.31 -0.09 (-0.63%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ELAN vs. BNTX, SMMT, INSM, TEVA, GMAB, RDY, MRNA, QGEN, VTRS, and ASNDShould you be buying Elanco Animal Health stock or one of its competitors? The main competitors of Elanco Animal Health include BioNTech (BNTX), Summit Therapeutics (SMMT), Insmed (INSM), Teva Pharmaceutical Industries (TEVA), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Moderna (MRNA), Qiagen (QGEN), Viatris (VTRS), and Ascendis Pharma A/S (ASND). These companies are all part of the "pharmaceutical products" industry. Elanco Animal Health vs. Its Competitors BioNTech Summit Therapeutics Insmed Teva Pharmaceutical Industries Genmab A/S Dr. Reddy's Laboratories Moderna Qiagen Viatris Ascendis Pharma A/S Elanco Animal Health (NYSE:ELAN) and BioNTech (NASDAQ:BNTX) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends. Do analysts prefer ELAN or BNTX? Elanco Animal Health presently has a consensus price target of $16.17, suggesting a potential upside of 12.30%. BioNTech has a consensus price target of $136.58, suggesting a potential upside of 22.52%. Given BioNTech's higher probable upside, analysts plainly believe BioNTech is more favorable than Elanco Animal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Elanco Animal Health 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.88BioNTech 0 Sell rating(s) 4 Hold rating(s) 13 Buy rating(s) 1 Strong Buy rating(s) 2.83 Which has more risk and volatility, ELAN or BNTX? Elanco Animal Health has a beta of 1.67, meaning that its share price is 67% more volatile than the S&P 500. Comparatively, BioNTech has a beta of 1.29, meaning that its share price is 29% more volatile than the S&P 500. Which has higher valuation & earnings, ELAN or BNTX? Elanco Animal Health has higher revenue and earnings than BioNTech. BioNTech is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioElanco Animal Health$4.44B1.61$338M$0.7419.45BioNTech$2.98B9.00-$719.92M-$3.40-32.79 Do institutionals and insiders hold more shares of ELAN or BNTX? 97.5% of Elanco Animal Health shares are held by institutional investors. Comparatively, 15.5% of BioNTech shares are held by institutional investors. 0.9% of Elanco Animal Health shares are held by insiders. Comparatively, 19.2% of BioNTech shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media prefer ELAN or BNTX? In the previous week, Elanco Animal Health had 3 more articles in the media than BioNTech. MarketBeat recorded 14 mentions for Elanco Animal Health and 11 mentions for BioNTech. Elanco Animal Health's average media sentiment score of 1.04 beat BioNTech's score of 0.97 indicating that Elanco Animal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elanco Animal Health 8 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioNTech 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is ELAN or BNTX more profitable? Elanco Animal Health has a net margin of 8.43% compared to BioNTech's net margin of -27.37%. Elanco Animal Health's return on equity of 7.54% beat BioNTech's return on equity.Company Net Margins Return on Equity Return on Assets Elanco Animal Health8.43% 7.54% 3.57% BioNTech -27.37%-3.94%-3.41% SummaryElanco Animal Health beats BioNTech on 12 of the 16 factors compared between the two stocks. Get Elanco Animal Health News Delivered to You Automatically Sign up to receive the latest news and ratings for ELAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ELAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELAN vs. The Competition Export to ExcelMetricElanco Animal HealthMED IndustryMedical SectorNYSE ExchangeMarket Cap$7.24B$3.77B$5.70B$21.03BDividend YieldN/A1.34%4.71%3.60%P/E Ratio19.4534.8928.1927.92Price / Sales1.61120.19391.9468.05Price / Cash6.4722.0636.3223.29Price / Book1.174.388.284.54Net Income$338M$189.47M$3.25B$993.24M7 Day Performance-4.12%-2.50%-2.00%-1.51%1 Month Performance0.74%-3.15%8.67%3.16%1 Year Performance11.60%-2.89%34.65%9.14% Elanco Animal Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELANElanco Animal Health3.2591 of 5 stars$14.40-1.3%$16.17+12.3%+11.4%$7.24B$4.44B19.459,000BNTXBioNTech1.4636 of 5 stars$108.91-1.0%$136.58+25.4%+28.7%$26.18B$2.98B-32.036,772Upcoming EarningsSMMTSummit Therapeutics2.9907 of 5 stars$26.34+0.5%$34.67+31.6%+148.1%$19.56B$700K-77.47110Upcoming EarningsINSMInsmed3.9281 of 5 stars$102.78+0.2%$108.47+5.5%+40.8%$19.50B$363.71M-17.271,271Positive NewsUpcoming EarningsTEVATeva Pharmaceutical Industries4.0949 of 5 stars$16.30+1.5%$24.71+51.7%-1.0%$18.69B$16.54B-14.1736,830News CoveragePositive NewsGap UpGMABGenmab A/S4.0342 of 5 stars$21.69-0.9%$37.80+74.3%-20.6%$13.92B$3.12B12.322,682Positive NewsAnalyst UpgradeRDYDr. Reddy's Laboratories2.6717 of 5 stars$14.57+0.6%$16.95+16.4%-10.0%$12.16B$3.81B22.0727,811Earnings ReportMRNAModerna4.3435 of 5 stars$30.97-0.9%$46.61+50.5%-73.3%$11.98B$3.24B-3.555,800Upcoming EarningsQGENQiagen3.6468 of 5 stars$48.06-0.6%$49.40+2.8%+18.7%$10.68B$1.98B120.495,765Upcoming EarningsVTRSViatris2.6216 of 5 stars$8.90+0.2%$10.40+16.9%-22.8%$10.45B$14.74B-2.8132,000ASNDAscendis Pharma A/S3.3866 of 5 stars$168.02-1.1%$223.07+32.8%+21.7%$10.39B$368.70M-26.751,017Analyst Forecast Related Companies and Tools Related Companies BNTX Competitors SMMT Competitors INSM Competitors TEVA Competitors GMAB Competitors RDY Competitors MRNA Competitors QGEN Competitors VTRS Competitors ASND Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ELAN) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thNew China tariffs hit August 12th—and Wall Street’s already moving. Banks and billionaires are quietly shif...American Alternative | SponsoredThe $1 Trillion Event Tesla Still Hasn’t Recovered FromIn 2010, a “Flash Crash” erased $1 trillion in minutes. Now, one trading legend says it’s happening again—insi...Brownstone Research | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredElon Musk: “This will transform civilization as we know it.”Robots are no longer science fiction — they’re the next trillion-dollar megatrend. According to Forbes, by ...Weiss Ratings | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elanco Animal Health Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Elanco Animal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
